US
(888) 440-0954
Home  |   Press  |  MedGenome to discuss its proprietary cancer immunotherapeutics platform

MedGenome to discuss its proprietary cancer immunotherapeutics platform

February 15, 2016

OncoPept is an integrated platform that interrogates tumor and its microenvironment to discover potential cancer vaccine candidates as therapeutics and biomarkers of response.

*
 
*
*